A patient with arteriosclerosis obliterans begins a treadmill walking program and develops leg pain after two minutes. What is the most appropriate action?

Prepare for the NPTE Scorebuilders OA Exam 1. Engage with flashcards and multiple choice questions, detailed explanations for each item. Achieve success in your exam!

Multiple Choice

A patient with arteriosclerosis obliterans begins a treadmill walking program and develops leg pain after two minutes. What is the most appropriate action?

Explanation:
In peripheral arterial disease, leg pain during walking is intermittent claudication caused by insufficient blood flow to the working muscles. The best approach during a supervised walking program is to stop walking when claudication begins and rest until the pain subsides, then resume walking at a comfortable pace. This rest–recovery pattern allows reperfusion, prevents worsening ischemia, and gradually builds endurance as the patient reinitiates activity. Pushing through the pain or forcing a longer walk without relief can worsen symptoms and fatigue. Decreasing speed or choosing a different exercise isn’t necessary if pain subsides with rest and the patient can resume walking, which is the standard, progressive method for improving walking tolerance in PAD.

In peripheral arterial disease, leg pain during walking is intermittent claudication caused by insufficient blood flow to the working muscles. The best approach during a supervised walking program is to stop walking when claudication begins and rest until the pain subsides, then resume walking at a comfortable pace. This rest–recovery pattern allows reperfusion, prevents worsening ischemia, and gradually builds endurance as the patient reinitiates activity. Pushing through the pain or forcing a longer walk without relief can worsen symptoms and fatigue. Decreasing speed or choosing a different exercise isn’t necessary if pain subsides with rest and the patient can resume walking, which is the standard, progressive method for improving walking tolerance in PAD.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy